Company Profile

Schrodinger Inc (AKA: Schrödinger LLC)
Profile last edited on: 2/19/2021      CAGE: 1CJB1      UEI: NSUESF38DS83

Business Identifier: Chemical simulation software: computational drug design
Year Founded
1990
First Award
1991
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

120 West 45th Street 17th Floor
New York, NY 10036
   (212) 295-5800
   info@schrodinger.com
   www.schrodinger.com
Location: Multiple
Congr. District: 12
County: New York

Public Profile

Based in Oregon with US faciliites in NY, CA, MD and MA; an overseas presence in Europe, Japan and India and having business partners in China and Korea, employing advanced computational methods that transform the way scientists design therapeutics and materials, Schrödinger, LLC develops chemical simulation software for use in pharmaceutical and biotechnology research. The company provides products ranging from general molecular modeling programs to a suite of drug design software, including ligand- and structure-based methods. Also offered are small-molecule drug discovery, biologics, materials science, and discovery informatics solutions; and PyMOL, a 3D molecular visualization solution. The company’s software allows scientists to accelerate their research and development activities, as well as to make novel discoveries. It serves pharmaceutical and biotech companies, universities, non-profit institutions, and governmental agencies, including supercomputing centers.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
250-500
Revenue Range
20M-50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : SDGR
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 2 NIH $1,359,974
Project Title: Commercial Software for Modeling of G Protein-Coupled Receptors
2003 1 NIH $99,987
Project Title: Modeling Metal-Containing Biological Systems
2000 2 NIH $826,347
Project Title: Polarizable Force Fields For Peptides And Proteins
1998 2 NSF $462,608
Project Title: Software for Fast and Accurate Calculations on Transition-Metal Systems
1998 1 NSF $100,000
Project Title: Accurate Thermochemistry for Large Systems

Key People / Management

  Ramy Farid -- President, Chief Executive Officer

  Charles Ardai

  Cony D'Cruz -- Senior Vice President, Business Development

  Richard Friesner -- Founder

  Wlliam Goddard -- Founder

  Jean-Marc Langlois

  Alessandro Monge -- Vice President, Strategic Business

  Mark Murcko -- Senior Vice President, Strategy

  Robert B Murphy

  Murco Ringnalda -- Chief Financial Officer, Co-Founder